A Global Approach To Medtech Regulation: The Post-EU Way Ahead For UK Industry?
As the UK looks to its future healthtech regulatory model after Brexit, the ABHI’s regulatory director Phil Brown suggests a system whereby the same product data can be used as the basis for entry not only to the EU, but also to global markets.
